Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Experimental hantavirus vaccine elicits strong antibody response in primates

24.10.2003


For the first time, scientists have demonstrated that an experimental vaccine to hantavirus pulmonary syndrome (HPS), a highly lethal disease, elicits a strong neutralizing antibody response in laboratory animals - a response that is key to preventing the virus from causing infection.

In addition, the antibodies, produced in nonhuman primates that received the vaccine, protected hamsters from disease even when administered 5 days after exposure.

These findings provide proof of concept in nonhuman primates for a vaccine against HPS, as well as for post exposure prophylactic treatment of HPS and a related disease known as hemorrhagic fever with renal syndrome (HFRS).



In an article published in last month’s Journal of Virology, investigators at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) describe using a naked DNA approach to develop a hantavirus vaccine. The technique involves vaccination with plasmid DNA that encodes a specific hantavirus gene. When the plasmid DNA is introduced into the cells of a vaccine recipient, using a harmless device called a "gene gun," the cloned gene is expressed and presented to the immune system.

According to senior author Jay W. Hooper, Ph.D., the USAMRIID team constructed an expression plasmid containing the full-length M genome segment of Andes virus, a South American hantavirus. Vaccination with the plasmid elicited a potent neutralizing antibody response in rhesus macaques that were vaccinated a total of four times at three-week intervals.

To look at the duration of that response, the team collected serum samples for about six months. The monkeys who received the Andes vaccine displayed robust antibody levels as long as 25 weeks after the last vaccination.

Hantaviruses are carried by rodents and have caused epidemics in Europe, Asia, and the Americas. Some cause HPS, while others are responsible for the more common HFRS. The viruses are pathogens of known military importance in endemic areas.

Currently there are no vaccines or antiviral drugs to protect against or treat HPS. The disease affects previously healthy individuals in all age groups, disease progression is rapid, and the case fatality rate is one of the highest for any acute viral disease known. In addition, there have been reports of person-to-person transmission of Andes virus in southern Argentina and Chile.

Having successfully vaccinated rhesus macaques with a hantavirus vaccine candidate, the USAMRIID scientists next asked whether the neutralizing antibody response elicited by the vaccine could protect hamsters from lethal hantavirus infection. The team had already developed a lethal-disease model of Andes virus in Syrian hamsters. To further explore this question, they tested serum from a monkey that had received the Andes vaccine for protective efficacy when administered to hamsters following challenge with the virus.

In these post-challenge experiments, 15 of 16 animals that received the antibody on day 3, 4, or 5 after challenge survived. The level of protection dropped significantly when the antibody was administered on day 6 or later. While all but one of the post-challenge survivors were infected with Andes virus, no deaths were observed.

"Aside from the immunogenicity of the vaccine in nonhuman primates, the most exciting thing about this was the indication that post-exposure prophylaxis might work--even five days out from exposure," Hooper commented. "When we administered antibody after challenge, we got nearly complete protection."

While the immediate need is for a vaccine against HFRS, the USAMRIID team believes the DNA vaccine approach could one day be used to develop a multivalent vaccine for hantaviruses that would be broadly protective against HPS and other forms of the disease.

"This work is an example of the many medical products that USAMRIID offers the Nation and the Department of Defense," said Colonel Erik A. Henchal, Ph.D., commander of the Institute. "This success is the product of years of dedicated basic and applied research by USAMRIID scientists."

Hooper’s co-authors were David M. Custer, Elizabeth G. Thompson, and Connie S. Schmaljohn, Ph.D., of USAMRIID, and Thomas G. Ksiazek, D.V.M., Ph.D., of the Centers for Disease Control and Prevention.

Caree Vander Linden | EurekAlert!
Further information:
http://www.usamriid.army.mil

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

Interactive software tool makes complex mold design simple

16.08.2018 | Information Technology

Study tracks inner workings of the brain with new biosensor

16.08.2018 | Health and Medicine

Fraunhofer HHI develops next-generation quantum communications technology in the UNIQORN project

16.08.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>